Kyowa Kirin Australia joins Medicines Australia
October 2023
Kyowa Kirin Australia is pleased to announce that we have been accepted as a new member of Medicines Australia.
We extend our thanks to Dr Anna Lavelle AM FTSE GAICD and the Medicines Australia Board as well as CEO, Elizabeth de Somer, and look forward to working closely with the team and our industry peers in support of timely and equitable access to innovative medicines for all Australians.
This important milestone comes as our company celebrates four years of operation in Australia.
As our business continues to grow and evolve, we remain focused on cutting-edge science to deliver novel medicines with life-changing value for Australians living with rare diseases and other unmet medical needs.
Medicines Australia is the industry body for the research-based medicines industry of Australia.
© 2023 All rights reserved. Kyowa Kirin Australia Pty Ltd, 68 York Street, Sydney, NSW 2000, Australia. www.kyowakirin.com/australia AU-NP-23-00023 Date of Preparation: Oct 2023